Search

Your search keyword '"Ferrone, Cristina R."' showing total 1,635 results
Start Over Author "Ferrone, Cristina R."
1,635 results on '"Ferrone, Cristina R."'

4. The Role of Adjuvant Therapy in Duodenal Adenocarcinoma and Intestinal Subtype Ampullary Carcinoma After Curative Resection

Author

Finton, Sarah, Bolm, Louisa, Nebbia, Martina, Petruch, Natalie, Férnandez-Del Castillo, Carlos, Qadan, Motaz, Lillemoe, Keith D., Wellner, Ulrich F., Distler, Marius, Zimmermann, Carolin, Weitz, Jürgen, Rückert, Felix, Rahbari, Nuh N., Reissfelder, Christoph, Nappo, Gennaro, Keck, Tobias, Zerbi, Alessandro, and Ferrone, Cristina R.

Published
2024
Full Text
View/download PDF

8. EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma

Author

Wu, Qibiao, Zhen, Yuanli, Shi, Lei, Vu, Phuong, Greninger, Patricia, Adil, Ramzi, Merritt, Joshua, Egan, Regina, Wu, Meng-Ju, Yin, Xunqin, Ferrone, Cristina R, Deshpande, Vikram, Baiev, Islam, Pinto, Christopher J, McLoughlin, Daniel E, Walmsley, Charlotte S, Stone, James R, Gordan, John D, Zhu, Andrew X, Juric, Dejan, Goyal, Lipika, Benes, Cyril H, and Bardeesy, Nabeel

Subjects
Digestive Diseases - (Gallbladder), Digestive Diseases, 6.1 Pharmaceuticals, Development of treatments and therapeutic interventions, Evaluation of treatments and therapeutic interventions, 5.1 Pharmaceuticals, Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Cholangiocarcinoma, ErbB Receptors, Humans, Protein Kinase Inhibitors, Pyrimidines, Receptor, Fibroblast Growth Factor, Type 2, Oncology and Carcinogenesis
Abstract

FGFR inhibitors are approved for the treatment of advanced cholangiocarcinoma harboring FGFR2 fusions. However, the response rate is moderate, and resistance emerges rapidly due to acquired secondary FGFR2 mutations or due to other less-defined mechanisms. Here, we conducted high-throughput combination drug screens, biochemical analysis, and therapeutic studies using patient-derived models of FGFR2 fusion-positive cholangiocarcinoma to gain insight into these clinical profiles and uncover improved treatment strategies. We found that feedback activation of EGFR signaling limits FGFR inhibitor efficacy, restricting cell death induction in sensitive models and causing resistance in insensitive models lacking secondary FGFR2 mutations. Inhibition of wild-type EGFR potentiated responses to FGFR inhibitors in both contexts, durably suppressing MEK/ERK and mTOR signaling, increasing apoptosis, and causing marked tumor regressions in vivo. Our findings reveal EGFR-dependent adaptive signaling as an important mechanism limiting FGFR inhibitor efficacy and driving resistance and support clinical testing of FGFR/EGFR inhibitor therapy for FGFR2 fusion-positive cholangiocarcinoma.SignificanceWe demonstrate that feedback activation of EGFR signaling limits the effectiveness of FGFR inhibitor therapy and drives adaptive resistance in patient-derived models of FGFR2 fusion-positive cholangiocarcinoma. These studies support the potential of combination treatment with FGFR and EGFR inhibitors as an improved treatment for patients with FGFR2-driven cholangiocarcinoma. This article is highlighted in the In This Issue feature, p. 1171.

Published
2022

10. Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients With Pancreatic Ductal Adenocarcinoma

Author

Qiao, Guoliang, Fong, Zhi Ven, Bolm, Louisa, Fernandez del-Castillo, Carlos, Ferrone, Cristina R., Servin-Rojas, Maximiliano, Pathak, Priyadarshini, Lau-Min, Kelsey, Allen, Jill N., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Parikh, Aparna R., Ryan, David P., Weekes, Colin D., Roberts, Hannah M., Wo, Jennifer Y., Hong, Theodore S., Lillemoe, Keith D., and Qadan, Motaz

Published
2024
Full Text
View/download PDF

15. CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma

Author

Giraudo, Lidia, Cattaneo, Giulia, Gammaitoni, Loretta, Iaia, Ilenia, Donini, Chiara, Massa, Annamaria, Centomo, Maria Laura, Basiricò, Marco, Vigna, Elisa, Pisacane, Alberto, Picciotto, Franco, Berrino, Enrico, Marchiò, Caterina, Merlini, Alessandra, Paruzzo, Luca, Poletto, Stefano, Caravelli, Daniela, Biolato, Andrea Michela, Bortolot, Valentina, Landoni, Elisa, Ventin, Marco, Ferrone, Cristina R., Aglietta, Massimo, Dotti, Gianpietro, Leuci, Valeria, Carnevale-Schianca, Fabrizio, and Sangiolo, Dario

Published
2023
Full Text
View/download PDF

16. Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment

Author

Wang, Yufeng, Drum, David L., Sun, Ruochuan, Zhang, Yida, Chen, Feng, Sun, Fengfei, Dal, Emre, Yu, Ling, Jia, Jingyu, Arya, Shahrzad, Jia, Lin, Fan, Song, Isakoff, Steven J., Kehlmann, Allison M., Dotti, Gianpietro, Liu, Fubao, Zheng, Hui, Ferrone, Cristina R., Taghian, Alphonse G., DeLeo, Albert B., Ventin, Marco, Cattaneo, Giulia, Li, Yongxiang, Jounaidi, Youssef, Huang, Peigen, Maccalli, Cristina, Zhang, Hanyu, Wang, Cheng, Yang, Jibing, Boland, Genevieve M., Sadreyev, Ruslan I., Wong, LaiPing, Ferrone, Soldano, and Wang, Xinhui

Published
2023
Full Text
View/download PDF

17. Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment

Author

Pulvirenti, Alessandra, Javed, Ammar A., Michelakos, Theodoros, Sekigami, Yurie, Zheng, Jian, Kalvin, Hannah L., McIntyre, Caitlin A., Nebbia, Martina, Chou, Joanne F., Gonen, Mithat, Raj, Nitya, Reidy-Lagunes, Diane L., Zureikat, Amer H., Ferrone, Cristina R., He, Jin, Wei, Alice C., Singhi, Aatur D, Pulvirenti, Alessandra, Paniccia, Alessandro, Wei, Alice, Zureikat, Amer H., Javed, Ammar A, McIntyre, Caitlin A, del Castillo, Carlos Fernandez, Wolfgang, Christopher L, Ferrone, Cristina R, Klimstra, David S, Reidy-Lagunes, Diane L, Thompson, Elizabeth, Fishman, Elliot K, Kalvin, Hannah L, Zheng, Jian, He, Jin, Chou, Joanne F, Cameron, John L, Lillemoe, Keith D, Lee, Kenneth K, Soares, Kevin C, Tang, Laura H, Nebbia, Martina, Makary, Marty A, Weiss, Matthew J, D’Angelica, Michael I, Gonen, Mithat, Qadan, Motaz, Raj, Nitya, Hruban, Ralph H, Bukhart, Richard A, Razi, Samrah, Kingham, T Peter, Michelakos, Theodoros, Deshpande, Vikram, Balachandran, Vinod P, Burn, William R, III, Jarnagin, William R, and Sekigami, Yurie

Published
2023
Full Text
View/download PDF

20. SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers

Author

Shi, Lei, Shen, William, Davis, Mindy I., Kong, Ke, Vu, Phuong, Saha, Supriya K., Adil, Ramzi, Kreuzer, Johannes, Egan, Regina, Lee, Tobie D., Greninger, Patricia, Shrimp, Jonathan H., Zhao, Wei, Wei, Ting-Yu, Zhou, Mi, Eccleston, Jason, Sussman, Jonathan, Manocha, Ujjawal, Weerasekara, Vajira, Kondo, Hiroshi, Vijay, Vindhya, Wu, Meng-Ju, Kearney, Sara E., Ho, Jeffrey, McClanaghan, Joseph, Murchie, Ellen, Crowther, Giovanna S., Patnaik, Samarjit, Boxer, Matthew B., Shen, Min, Ting, David T., Kim, William Y., Stanger, Ben Z., Deshpande, Vikram, Ferrone, Cristina R., Benes, Cyril H., Haas, Wilhelm, Hall, Matthew D., and Bardeesy, Nabeel

Published
2023
Full Text
View/download PDF

23. Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients with Pancreatic Ductal Adenocarcinoma

Author

Qiao, Guoliang, Fong, Zhi Ven, Bolm, Louisa, Fernandez del-Castillo, Carlos, Ferrone, Cristina R, Servin-Rojas, Maximiliano, Pathak, Priyadarshini, Lau-Min, Kelsey, Allen, Jill N, Blaszkowsky, Lawrence S, Clark, Jeffrey W, Parikh, Aparna R, Ryan, David P, Weekes, Colin D, Roberts, Hannah M, Wo, Jennifer Y, Hong, Theodore S, Lillemoe, Keith D, and Qadan, Motaz

Published
2023
Full Text
View/download PDF

26. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment

Author

Hwang, William L., Jagadeesh, Karthik A., Guo, Jimmy A., Hoffman, Hannah I., Yadollahpour, Payman, Reeves, Jason W., Mohan, Rahul, Drokhlyansky, Eugene, Van Wittenberghe, Nicholas, Ashenberg, Orr, Farhi, Samouil L., Schapiro, Denis, Divakar, Prajan, Miller, Eric, Zollinger, Daniel R., Eng, George, Schenkel, Jason M., Su, Jennifer, Shiau, Carina, Yu, Patrick, Freed-Pastor, William A., Abbondanza, Domenic, Mehta, Arnav, Gould, Joshua, Lambden, Conner, Porter, Caroline B. M., Tsankov, Alexander, Dionne, Danielle, Waldman, Julia, Cuoco, Michael S., Nguyen, Lan, Delorey, Toni, Phillips, Devan, Barth, Jaimie L., Kem, Marina, Rodrigues, Clifton, Ciprani, Debora, Roldan, Jorge, Zelga, Piotr, Jorgji, Vjola, Chen, Jonathan H., Ely, Zackery, Zhao, Daniel, Fuhrman, Kit, Fropf, Robin, Beechem, Joseph M., Loeffler, Jay S., Ryan, David P., Weekes, Colin D., Ferrone, Cristina R., Qadan, Motaz, Aryee, Martin J., Jain, Rakesh K., Neuberg, Donna S., Wo, Jennifer Y., Hong, Theodore S., Xavier, Ramnik, Aguirre, Andrew J., Rozenblatt-Rosen, Orit, Mino-Kenudson, Mari, Castillo, Carlos Fernandez-del, Liss, Andrew S., Ting, David T., Jacks, Tyler, and Regev, Aviv

Published
2022
Full Text
View/download PDF

27. TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Author

Goyal, Lipika, Shi, Lei, Liu, Leah Y, de la Cruz, Ferran Fece, Lennerz, Jochen K, Raghavan, Srivatsan, Leschiner, Ignaty, Elagina, Liudmila, Siravegna, Giulia, Ng, Raymond WS, Vu, Phuong, Patra, Krushna C, Saha, Supriya K, Uppot, Raul N, Arellano, Ron, Reyes, Stephanie, Sagara, Takeshi, Otsuki, Sachie, Nadres, Brandon, Shahzade, Heather A, Dey-Guha, Ipsita, Fetter, Isobel J, Baiev, Islam, Van Seventer, Emily E, Murphy, Janet E, Ferrone, Cristina R, Tanabe, Kenneth K, Deshpande, Vikram, Harding, James J, Yaeger, Rona, Kelley, Robin K, Bardelli, Alberto, Iafrate, A John, Hahn, William C, Benes, Cyril H, Ting, David T, Hirai, Hiroshi, Getz, Gad, Juric, Dejan, Zhu, Andrew X, Corcoran, Ryan B, and Bardeesy, Nabeel

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Cancer, Genetics, Adenosine Triphosphate, Adult, Aged, Cell Line, Tumor, Cholangiocarcinoma, Circulating Tumor DNA, Drug Resistance, Neoplasm, Female, Humans, Male, Middle Aged, Mutation, Oncogene Proteins, Fusion, Phenylurea Compounds, Protein Kinase Inhibitors, Pyrimidines, Receptor, Fibroblast Growth Factor, Type 2, Signal Transduction, Structure-Activity Relationship, Tomography, X-Ray Computed, Biochemistry and cell biology, Oncology and carcinogenesis
Abstract

ATP-competitive fibroblast growth factor receptor (FGFR) kinase inhibitors, including BGJ398 and Debio 1347, show antitumor activity in patients with intrahepatic cholangiocarcinoma (ICC) harboring activating FGFR2 gene fusions. Unfortunately, acquired resistance develops and is often associated with the emergence of secondary FGFR2 kinase domain mutations. Here, we report that the irreversible pan-FGFR inhibitor TAS-120 demonstrated efficacy in 4 patients with FGFR2 fusion-positive ICC who developed resistance to BGJ398 or Debio 1347. Examination of serial biopsies, circulating tumor DNA (ctDNA), and patient-derived ICC cells revealed that TAS-120 was active against multiple FGFR2 mutations conferring resistance to BGJ398 or Debio 1347. Functional assessment and modeling the clonal outgrowth of individual resistance mutations from polyclonal cell pools mirrored the resistance profiles observed clinically for each inhibitor. Our findings suggest that strategic sequencing of FGFR inhibitors, guided by serial biopsy and ctDNA analysis, may prolong the duration of benefit from FGFR inhibition in patients with FGFR2 fusion-positive ICC. SIGNIFICANCE: ATP-competitive FGFR inhibitors (BGJ398, Debio 1347) show efficacy in FGFR2-altered ICC; however, acquired FGFR2 kinase domain mutations cause drug resistance and tumor progression. We demonstrate that the irreversible FGFR inhibitor TAS-120 provides clinical benefit in patients with resistance to BGJ398 or Debio 1347 and overcomes several FGFR2 mutations in ICC models.This article is highlighted in the In This Issue feature, p. 983.

Published
2019

28. Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer

Author

Ligorio, Matteo, Sil, Srinjoy, Malagon-Lopez, Jose, Nieman, Linda T, Misale, Sandra, Di Pilato, Mauro, Ebright, Richard Y, Karabacak, Murat N, Kulkarni, Anupriya S, Liu, Ann, Vincent Jordan, Nicole, Franses, Joseph W, Philipp, Julia, Kreuzer, Johannes, Desai, Niyati, Arora, Kshitij S, Rajurkar, Mihir, Horwitz, Elad, Neyaz, Azfar, Tai, Eric, Magnus, Neelima KC, Vo, Kevin D, Yashaswini, Chittampalli N, Marangoni, Francesco, Boukhali, Myriam, Fatherree, Jackson P, Damon, Leah J, Xega, Kristina, Desai, Rushil, Choz, Melissa, Bersani, Francesca, Langenbucher, Adam, Thapar, Vishal, Morris, Robert, Wellner, Ulrich F, Schilling, Oliver, Lawrence, Michael S, Liss, Andrew S, Rivera, Miguel N, Deshpande, Vikram, Benes, Cyril H, Maheswaran, Shyamala, Haber, Daniel A, Fernandez-Del-Castillo, Carlos, Ferrone, Cristina R, Haas, Wilhelm, Aryee, Martin J, and Ting, David T

Subjects
Biochemistry and Cell Biology, Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Biological Sciences, Rare Diseases, Genetics, Digestive Diseases, Stem Cell Research, Pancreatic Cancer, Cancer, Stem Cell Research - Nonembryonic - Human, 2.1 Biological and endogenous factors, Aetiology, Animals, Cancer-Associated Fibroblasts, Carcinoma, Pancreatic Ductal, Cell Proliferation, Coculture Techniques, Epithelial-Mesenchymal Transition, Female, HEK293 Cells, Heterografts, Humans, Mice, Mice, Inbred NOD, Mice, SCID, Mitogen-Activated Protein Kinases, Pancreatic Neoplasms, RNA-Seq, STAT3 Transcription Factor, Stromal Cells, Transfection, Tumor Microenvironment, mass spectrometry, pancreatic cancer, pancreatic ductal adenocarcinoma, single cell RNA-sequencing, single cell spatial analysis, stromal microenvironment, tumor architecture, Medical and Health Sciences, Developmental Biology, Biological sciences, Biomedical and clinical sciences
Abstract

Single-cell technologies have described heterogeneity across tissues, but the spatial distribution and forces that drive single-cell phenotypes have not been well defined. Combining single-cell RNA and protein analytics in studying the role of stromal cancer-associated fibroblasts (CAFs) in modulating heterogeneity in pancreatic cancer (pancreatic ductal adenocarcinoma [PDAC]) model systems, we have identified significant single-cell population shifts toward invasive epithelial-to-mesenchymal transition (EMT) and proliferative (PRO) phenotypes linked with mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription 3 (STAT3) signaling. Using high-content digital imaging of RNA in situ hybridization in 195 PDAC tumors, we quantified these EMT and PRO subpopulations in 319,626 individual cancer cells that can be classified within the context of distinct tumor gland "units." Tumor gland typing provided an additional layer of intratumoral heterogeneity that was associated with differences in stromal abundance and clinical outcomes. This demonstrates the impact of the stroma in shaping tumor architecture by altering inherent patterns of tumor glands in human PDAC.

Published
2019

29. A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter study

Author

Javed, Ammar A., Pulvirenti, Alessandra, Zheng, Jian, Michelakos, Theodoros, Sekigami, Yurie, Razi, Samrah, Burkhart, Richard A., Burns, William R., Makary, Marty A., Fishman, Elliot K., Hruban, Ralph H., Thompson, Elizabeth, Klimstra, David S., Deshpande, Vikram, Singhi, Aatur D., Kingham, T. Peter, D’Angelica, Michael, Balachandran, Vinod P., Drebin, Jeff, Soares, Kevin C., Jarnagin, William R., Fernandez del Castillo, Carlos, Lillemoe, Keith, Qadan, Motaz, Paniccia, Alessandro, Lee, Kenneth K., Weiss, Matthew J., Wolfgang, Christopher L., Cameron, John L., Wei, Alice C., Zureikat, Amer H., Ferrone, Cristina R., He, Jin, and McIntyre, Caitlin A.

Published
2022
Full Text
View/download PDF

30. Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy

Author

Qiao, Guoliang, Ilagan, Crisanta H., Fernandez-del Castillo, Carlos, Ferrone, Cristina R., Janseen, Quisette P., Balachandran, Vinod P., Sell, Naomi M., Drebin, Jeffrey A., Hank, Thomas, Kingham, T. Peter, D’Angelica, Michael I., Jarnagin, William R., Lillemoe, Keith D., Wei, Alice C., and Qadan, Motaz

Published
2022
Full Text
View/download PDF

32. Effects of a perioperative geriatric intervention for older adults with Cancer: A randomized clinical trial

Author

Nipp, Ryan D., Qian, Carolyn L., Knight, Helen P., Ferrone, Cristina R., Kunitake, Hiroko, Castillo, Carlos Fernandez-del, Lanuti, Michael, Qadan, Motaz, Ricciardi, Rocco, Lillemoe, Keith D., Temel, Brandon, Hashmi, Ardeshir Z., Scott, Erin, Stevens, Erin, Williams, Grant R., Fong, Zhi Ven, O'Malley, Terrence A., Franco-Garcia, Esteban, Horick, Nora K., Jackson, Vicki A., Greer, Joseph A., El-Jawahri, Areej, and Temel, Jennifer S.

Published
2022
Full Text
View/download PDF

33. Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapy

Author

Maeda, Shimpei, Mederos, Michael A., Chawla, Akhil, Moore, Alexandra M., Shoucair, Sami, Yin, Lingdi, Burkhart, Richard A., Cameron, John L., Park, Joon Y., Girgis, Mark D., Wainberg, Zev A., Hines, O. Joe, Fernandez-Del Castillo, Carlos, Qadan, Motaz, Lillemoe, Keith D., Ferrone, Cristina R., He, Jin, Wolfgang, Christopher L., Burns, William R., Yu, Jun, and Donahue, Timothy R.

Published
2022
Full Text
View/download PDF

36. Response to Commentary on ‘“Long-Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort”

Author

Bolm, Louisa, Nebbia, Martina, Wei, Alice C., Zureikat, Amer H., Fernández-del Castillo, Carlos, Zheng, Jian, Pulvirenti, Alessandra, Javed, Ammar A., Sekigami, Yurie, Petruch, Natalie, Qadan, Motaz, Lillemoe, Keith D., He, Jin, and Ferrone, Cristina R.

Published
2023
Full Text
View/download PDF

40. Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy

Author

Michelakos, Theodoros, Sekigami, Yurie, Kontos, Filippos, Fernández-del Castillo, Carlos, Qadan, Motaz, Deshpande, Vikram, Ting, David T., Clark, Jeffrey W., Weekes, Colin D., Parikh, Aparna, Ryan, David P., Wo, Jennifer Y., Hong, Theodore S., Allen, Jill N., Catalano, Onofrio, Warshaw, Andrew L., Lillemoe, Keith D., and Ferrone, Cristina R.

Published
2021
Full Text
View/download PDF

41. Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal Carcinomatosis

Author

Furtado, Felipe S., Wu, Mark Z., Esfahani, Shadi A., Ferrone, Cristina R., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Ryan, David P., Goyal, Lipika, Franses, Joseph W., Wo, Jennifer Y., Hong, Theodore S., Qadan, Motaz, Tanabe, Kenneth K., Weekes, Colin D., Cusack, James C., Crafa, Francesco, Mahmood, Umar, Anderson, Mark A., Mojtahed, Amirkasra, Hahn, Peter F., Caravan, Peter, Kilcoyne, Aoife, Vangel, Mark, Striar, Robin M., Rosen, Bruce R., and Catalano, Onofrio A.

Published
2023
Full Text
View/download PDF

43. Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomes

Author

Sridharan, Vishwajith, Mino-Kenudson, Mari, Cleary, James M., Rahma, Osama E., Perez, Kimberly, Clark, Jeffrey W., Clancy, Thomas E., Rubinson, Douglas A., Goyal, Lipika, Bazerbachi, Fateh, Visrodia, Kavel H., Qadan, Motaz, Parikh, Aparna, Ferrone, Cristina R., Casey, Brenna W., Fernandez-Del Castillo, Carlos, Ryan, David Patrick, Lillemoe, Keith D., Warshaw, Andrew L., Krishnan, Kumar, and Hernandez-Barco, Yasmin G.

Published
2021
Full Text
View/download PDF

48. Interobserver Variability in the International Study Group for Pancreatic Surgery (ISGPS)-Defined Complications After Pancreatoduodenectomy

Author

Hendriks, Tessa E., Balduzzi, Alberto, van Dieren, Susan, Suurmeijer, J. Annelie, Salvia, Roberto, Stoop, Thomas F., Del Chiaro, Marco, Mieog, Sven D., Nielen, Mark, Zani, Sabino, Nussbaum, Daniel, Hackert, Thilo, Izbicki, Jakob R., Javed, Ammar A., Hewitt, D. Brock, Koerkamp, Bas Groot, de Wilde, Roeland F., Miao, Yi, Jiang, Kuirong, Nakata, Kohei, Nakamura, Masafumi, Jang, Jin-Young, Lee, Mirang, Ferrone, Cristina R., Shrikhande, Shailesh V., Chaudhari, Vikram A., Busch, Olivier R., Siriwardena, Ajith K., Strobel, Oliver, Werner, Jens, Bonsing, Bert A., Marchegiani, Giovanni, Besselink, Marc G., Michiels, Nynke, Rebattu, Valerie, Casciani, Fabio, Paiella, Salvatore, Mele, Serena, Wolfgang, Christopher, Kaslow, Sarah, Allen, Peter, Blazer, Dan, Franklin, Oskar, Franco, Salvador Rodriguez, Kirsch, Michael, Sugawara, Toshitaka, Theijse, Rutger, Capelle, Marie, Haen, Roel, Nebbia, Martina, Bolm, Louisa, Fong, Zhi Ven, Chopde, Amit, Kunte, Aditya, Gundavda, Kaival, Varty, Gurudutt, Ikenaga, Naoki, Abe, Toshiya, Lu, Zipeng, Cai, Baobao, Götz, Mara, Uzunoglu, Faik G., Bardenhagen, Jan, Gehrisch, Fiete, Yun, Won-Gun, Han, Youngmin, Barreto, Savio George A. Da P., Asbun, Horacio, Vollmer, Charles, Falconi, Massimo, Hartwig, Werner, Adham, Mustapha, Fingerhut, Abe, Bockhorn, Maximillian, Zyromski, Nicholas, Boggi, Ugo, Sato, Asahi, Halloran, Christopher, Butturini, Giovanni, Fusai, Giuseppe Kito, Friess, Helmut, Lillemoe, Keith D, and Conlon, Kevin

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results